QuantaSing Group vs. 17 Education & Technology: Financial Face-offby Lilu Anderson 23.06.2024Compare QuantaSing Group (QSG) and 17 Education & Technology Group (YQ) in terms of risk, analyst ratings, ownership, profitability, and ...
Apple and Meta Discuss AI Partnership, WSJ Reportsby Mark Eisenberg 23.06.2024Apple and Meta eye AI partnership, reports WSJ. This tech alliance could revolutionize the tech landscape. Stay informed on potential ...
5 Big AI Analyst Calls: Downgrade for Palantir, Micron Upgradedby Mark Eisenberg 23.06.2024"Key Analyst Moves This Week: Palantir Downgraded, Micron's Price Target Hiked. Microsoft, Apple, and Adeia emerge as strong AI contenders."
Bitcoin Bull Run Delayed to 2024 Amid Market Challengesby John Darbie 23.06.2024"Bitcoin bull run delayed till late 2024; QCP Capital, miner pressures, German BTC sales, and ETF sell-offs weigh on market. ...
2024 Bitcoin Bull Run: Election Impact and Miner Sell-Offby John Darbie 23.06.2024Is a Bitcoin bull run looming for 2024? Experts eye a potential September surge. Learn about price trends, miner sell-offs, ...
Egypt Delivers 28,000 Eco-Friendly Cars Amid Challengesby Mark Eisenberg 23.06.2024Despite economic hurdles, Egypt's Finance Minister announced 28,000 new eco-friendly cars delivered, supporting green transport and local industry.
ExCobalt Cyber Gang Unleashes GoRed Backdoor on Russiaby Lilu Anderson 23.06.2024ExCobalt cyber gang targets Russian sectors with GoRed backdoor, focusing on government, IT, and mining sectors using advanced espionage tools.
Czech National Bank Increases Stake in Tyler Technologiesby Lilu Anderson 22.06.2024Czech National Bank boosts stake in Tyler Technologies (NYSE:TYL) by 0.6% to $3.15M in Q1. Major investors and analysts show ...
Ethereum Defies Crypto Slump, Eyes Dogecoin in Market Cap Chaseby John Darbie 22.06.2024"Ethereum defies a sinking crypto market while Bitcoin and meme coins plummet. Market experts are divided over the future of ...
U.S. Crackdown on Chinese Biotech Could Harm Patientsby Lilu Anderson 22.06.2024America's crackdown on Chinese biotech could lead to drug shortages and higher costs, impacting patients without delivering promised security benefits.